文献速递运动医学关节外科

内侧半月板同种异体移植联合或不联合胫骨高位截骨的临床结局:随访至8年的病例对照研究

Clinical Outcomes of Medial Meniscal Allograft Transplantation With or Without High Tibial Osteotomy: A Case-Control Study Up to 8 Years of Follow-up.
PubMed 文献 · Am J Sports Med · 2024-05-20

该病例对照研究纳入55例接受内侧半月板同种异体移植(MAT)联合胫骨高位截骨(HTO)的患者,并按人口学特征模糊匹配55例单纯内侧MAT患者,随访平均5.4年(至8年)。两组末次随访临床评分均显著改善,组间无显著差异;但MAT+HTO组手术失败生存率显著低于单纯MAT组(风险比5.1,P=.049)。作者认为手术矫正的下肢力线异常并非内侧MAT的禁忌证,但同期HTO与随时间略高的失败率相关。

要点

  • 内侧MAT联合HTO与单纯内侧MAT在中远期随访中临床结果相似。
  • MAT+HTO组手术失败生存率显著更低(风险比5.1,P=.049)。
  • 手术处理的下肢力线异常并非内侧MAT的禁忌证。

核心结论

  • 接受内侧MAT+HTO的患者在中远期随访中显示出与单纯内侧MAT患者相似的临床结果,因此手术矫正的下肢力线异常并非内侧MAT的禁忌证。
  • 同期HTO的需求与随时间略高的失败率相关。

研究设计与样本

  • 队列研究,证据等级3级。
  • 共55例患者接受关节镜下软组织技术内侧MAT联合HTO(平均年龄41.3±10.4岁;9例女性);经人口学特征模糊病例对照匹配后,纳入55例接受单纯内侧MAT的对照。
  • 采用Kaplan-Meier法进行生存分析,以手术失败、临床失败(Lysholm评分<65)和再手术为终点。

主要发现

  • 平均随访时间5.4年,最长至8年;所有结局在末次随访时均显著改善(P<.001)。
  • MAT组与MAT+HTO组在术前和末次随访时均无差异(P>.05)。
  • 末次随访时,MAT+HTO组55例中8例(14.5%)Lysholm评分<65,MAT组55例中9例(16.4%)Lysholm评分<65(P=.885)。
  • 总体90%的患者表示无论是否联合手术均愿意再次接受手术。
  • 手术失败共6/110例(5.5%):MAT+HTO组5/55例(9.1%),MAT组1/55例(1.8%)(P=.093)。

临床怎么用

  • 作者认为手术矫正的下肢力线异常并非内侧MAT的禁忌证。
  • 作者指出同期HTO的需求与随时间略高的失败率相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Satisfactory clinical results of meniscal allograft transplantation (MAT) have been reported in recent years. However, it remains unclear whether the clinical outcomes of MAT when combined with an osteotomy are inferior to those of isolated MAT. PURPOSE: To compare the survival rates and clinical outcomes of patients who received isolated medial MAT with those of patients undergoing medial MAT combined with high tibial osteotomy (HTO). STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: A total of 55 patients underwent arthroscopic medial MAT using the soft tissue technique and HTO (mean age, 41.3 ± 10.4 years; 9 female); after fuzzy case-control matching on demographics, 55 controls who underwent isolated medial MAT were also included. Survival analyses were performed using the Kaplan-Meier method with surgical failure, clinical failure (Lysholm score, <65), and reoperation as endpoints. Subjective clinical scores were collected preoperatively and at the final follow-up. RESULTS: The mean follow-up time was 5.4 years, up to 8 years. All outcomes significantly improved at the last follow-up (P < .001). No differences were identified between MAT and MAT + HTO groups preoperatively and at the last follow-up (P > .05). At the final follow-up, 8 of 55 (14.5%) of the MAT + HTO patients and 9 of 55 (16.4%) of the MAT patients had a Lysholm score <65 (P = .885). Overall, 90% of the patients declared they would repeat the surgery regardless of the combined procedure. Surgical failure was identified in 6 of 110 (5.5%) patients: 5 of 55 (9.1%) in the MAT + HTO group and 1 of 55 (1.8%) in the MAT group (P = .093). Clinical failure was identified in 19 of 110 (17.3%) patients: 11 of 55 (20%) in the MAT + HTO group and 8 of 55 (14.5%) in the MAT group (P = .447). A significantly lower survivorship from surgical failure was identified in the MAT + HTO group (hazard ratio, 5.1; P = .049), while no differences in survivorship from reoperation and clinical failure were identified (P > .05). CONCLUSION: Patients undergoing medial MAT + HTO showed similar clinical results to patients undergoing isolated medial MAT at midterm follow-up, and thus a surgically addressed malalignment does not represent a contraindication for medial MAT. However, the need for a concomitant HTO is associated with a slightly higher failure rate over time.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Grassi A, Lucidi GA, Di Paolo S, et al. Clinical Outcomes of Medial Meniscal Allograft Transplantation With or Without High Tibial Osteotomy: A Case-Control Study Up to 8 Years of Follow-up. Am J Sports Med. 2024. PMID: 38767945. doi:10.1177/03635465241248822

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。